NASDAQ:ABEO
Abeona Therapeutics Inc. Stock News
$4.45
+0.0500 (+1.14%)
At Close: May 09, 2024
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligence
12:00am, Monday, 11'th May 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy using Artificial Intelligence
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q1 2020 Results - Earnings Call Transcript
05:07pm, Saturday, 09'th May 2020
Selecta Biosciences, Inc. (NASDAQ:SELB) Q1 2020 Earnings Conference Call May 07, 2020, 08:30 ET Company Participants Elona Kogan - General Counsel & Corpora
Catalent, Inc. (CTLT) CEO John Chiminski on Q3 2020 Results - Earnings Call Transcript
03:20pm, Saturday, 09'th May 2020
Catalent, Inc. (NYSE:CTLT) Q3 2020 Earnings Conference Call May 5, 2020 08:15 ET Company Participants Paul Surdez - Vice President, Investor Relations John Chim
Pacira's (PCRX) Q1 Earnings Top Estimates, Revenues Rise Y/Y
04:58pm, Friday, 08'th May 2020
Pacira (PCRX) beats on both earnings and revenues in the first quarter of 2020. The company temporarily suspends 2020 guidance in the wake of the COVID-19 pandemic.
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates
05:59pm, Thursday, 07'th May 2020
Horizon Therapeutics (HZNP) beat on earnings and sales in the first quarter of 2020. The company lifts net sales guidance for the full year.
Taysha Gene Therapies Announces Presentations Highlighting Programs and Platform Technologies at #ASGCT20
Abeona Therapeutics Reports First Quarter Financial Results and Business Updates
08:14pm, Wednesday, 06'th May 2020
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced first quarter 2020 financial results, which will be discussed on a conference call scheduled for Th
May 02, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market 2020...
Moving Average Crossover Alert: Abeona Therapeutics
03:08pm, Wednesday, 29'th Apr 2020
Abeona Therapeutics is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Top Ranked Momentum Stocks to Buy for April 28th
03:04pm, Tuesday, 28'th Apr 2020
Top Ranked Momentum Stocks to Buy for April 28th
Asklepios BioPharmaceutical Acquires BrainVectis | FinSMEs
11:33am, Monday, 27'th Apr 2020
Asklepios BioPharmaceutical acquired BrainVectis, a Paris, France-based gene therapy company and French National Institute for Health and Medical Research (INSERM) spin-out with expertise and an intel
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
03:39pm, Friday, 24'th Apr 2020
On Vertex's (VRTX) first-quarter earnings call, investor focus will be on the sales uptake of its newly-launched CF drug, Trikafta.
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
03:39pm, Friday, 24'th Apr 2020
On Vertex's (VRTX) first-quarter earnings call, investor focus will be on the sales uptake of its newly-launched CF drug, Trikafta.
Is a Beat in Store for Abeona (ABEO) This Earnings Season?
02:35pm, Friday, 24'th Apr 2020
Abeona's (ABEO) operating expenses are expected to have increased in the first quarter driven by clinical studies on its lead gene therapy candidate.
